Fig. 1 | Scientific Reports

Fig. 1

From: Plasma-activated solutions reverse chronic deltamethrin exposure induced intestinal injury via rebalancing redox homeostasis and counteracting cellular senescence

Fig. 1

PAS alleviated DLM-induced intestinal mucosal barrier impairment (A) Schematic diagram of PAS generation apparatus. (B) Schematic of PAS therapeutic intervention in chronic low-dose DLM-exposed murine models (n = 10). (C) PAS administration reversed DLM-induced body weight loss in mice (n = 10). (D) PAS intake reduced the elevated DAI scores induced by DLM (n = 10). (E,F) DLM exposure markedly reduces colon length, whereas PAS treatment significantly increase colon length compared to the DLM group. Administration of PAS alone have no effect on colon length relative to the control group (n = 10). Data were presented with mean ± SD. *p < 0.05, ** p < 0.01, *** p < 0.001, ns: no significance.

Back to article page